Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms
Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018-2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Marine drugs - 18(2020), 12 vom: 02. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Ya-Nan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bioactivity |
---|
Anmerkungen: |
Date Completed 07.09.2021 Date Revised 30.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/md18120614 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM318425947 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM318425947 | ||
003 | DE-627 | ||
005 | 20240330234237.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/md18120614 |2 doi | |
028 | 5 | 2 | |a pubmed24n1356.xml |
035 | |a (DE-627)NLM318425947 | ||
035 | |a (NLM)33276592 | ||
035 | |a (PII)E614 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Ya-Nan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.09.2021 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018-2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a bioactivity | |
650 | 4 | |a deep-sea actinomycetes | |
650 | 4 | |a deep-sea fungi | |
650 | 4 | |a secondary metabolites | |
650 | 7 | |a Biological Products |2 NLM | |
700 | 1 | |a Meng, Ling-Hong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Bin-Gui |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Marine drugs |d 2007 |g 18(2020), 12 vom: 02. Dez. |w (DE-627)NLM179368389 |x 1660-3397 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2020 |g number:12 |g day:02 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/md18120614 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2020 |e 12 |b 02 |c 12 |